Clinical Trials Directory

Trials / Conditions / Lung Cancer Non-small Cell Stage IV

Lung Cancer Non-small Cell Stage IV

9 registered clinical trials studyying Lung Cancer Non-small Cell Stage IV — 1 currently recruiting.

StatusTrialSponsorPhase
WithdrawnStudy to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer
NCT06555263
Sutro Biopharma, Inc.Phase 2
Not Yet RecruitingPhase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung Cancer
NCT06463171
Shanghai Pulmonary Hospital, Shanghai, ChinaPhase 2
UnknownOsimertinib as 1st Line Therapy for Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer
NCT05127382
Hellenic Cooperative Oncology Group—
Active Not RecruitingStudy of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC
NCT03769103
British Columbia Cancer AgencyPhase 2
CompletedCombination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients
NCT04184921
Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityPhase 2
CompletedA Study of Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung Cancer
NCT03866993
AkesoPhase 3
TerminatedA Study of Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung Cancer
NCT03866980
AkesoPhase 3
UnknownEvaluation of Efficacy and Toxicity of Nivolumab Monotherapy for Advanced Non-small Cell Lung Cancer After Fir
NCT03692442
Guangzhou Institute of Respiratory Disease—
TerminatedSurvival imProvement in Lung cancEr iNduced by DenOsUmab theRapy
NCT02129699
ETOP IBCSG Partners FoundationPhase 3